These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 35389583)

  • 1. Safety and Efficacy of Intense Pulsed Light With Radiofrequency in United States Hidradenitis Suppurativa Patients.
    Lyons A; Narla S; Kohli I; Zubair R; Jacobsen G; Ceresnie M; Parks-Miller A; Hamzavi I
    J Drugs Dermatol; 2022 Apr; 21(4):430-432. PubMed ID: 35389583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined treatment of hidradenitis suppurativa with intense pulsed light (IPL) and radiofrequency (RF).
    Wilden S; Friis M; Tuettenberg A; Staubach-Renz P; Wegner J; Grabbe S; von Stebut E
    J Dermatolog Treat; 2021 Aug; 32(5):530-537. PubMed ID: 31609667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of radiofrequency in the treatment of hidradenitis suppurativa; a systematic review.
    Nilforoushzadeh MA; Heidari N; Heidari A; Ghane Y; Hosseini S; Lotfi Z; Jaffary F; Nobari MN; Aghamiri ZS; Nobari NN
    Lasers Med Sci; 2024 May; 39(1):139. PubMed ID: 38795173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of hidradenitis suppurativa with intense pulsed light: a prospective study.
    Highton L; Chan WY; Khwaja N; Laitung JKG
    Plast Reconstr Surg; 2011 Aug; 128(2):459-466. PubMed ID: 21788837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Laser and Light-Based Treatment Modalities for the Management of Hidradenitis Suppurativa.
    Lyons AB; Townsend SM; Turk D; Narla S; Baah N; Hamzavi IH
    Am J Clin Dermatol; 2020 Apr; 21(2):237-243. PubMed ID: 31845121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic Review of Light-Based Treatments for Hidradenitis Suppurativa.
    Gracia Cazaña T; Berdel Díaz LV; Martín Sánchez JI; Querol Nasarre I; Gilaberte Y
    Actas Dermosifiliogr (Engl Ed); 2020 Mar; 111(2):89-106. PubMed ID: 31870491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Intense pulsed light treatment for hidradenitis suppurativa: a within-person randomized controlled trial].
    Andersen PL; Riis PT; Thorlacius L; Sigsgaard V; Nielsen CW; Chafranska L; Westergaard C; Jemec GB; Saunte DM
    Eur J Dermatol; 2020 Dec; 30(6):723-729. PubMed ID: 33300880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness and safety of topical 15% resorcinol in the management of mild-to-moderate hidradenitis suppurativa: A cohort study.
    Cordero-Ramos J; Barros-Tornay R; Toledo-Pastrana T; Ferrándiz L; Calleja-Hernández MÁ; Moreno-Ramírez D
    J Dermatol; 2022 Apr; 49(4):459-462. PubMed ID: 34984726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LAight® Therapy Significantly Enhances Treatment Efficacy of 16 Weeks of Topical Clindamycin Solution in Hurley I and II Hidradenitis Suppurativa: Results from Period A of RELIEVE, a Multicenter Randomized, Controlled Trial.
    Schultheis M; Staubach P; Nikolakis G; Grabbe S; Ruckes C; von Stebut E; Kirschner U; Matusiak Ł; Szepietowski JC
    Dermatology; 2022; 238(3):476-486. PubMed ID: 34535610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two Cases of Hidradenitis Suppurativa Treated with Adalimumab at the Department of Dermatology and Venereology, Clinical Hospital Mostar.
    Lovrić I; Brkić J; Ćorluka M; Čović M; Pejić J; Zeljko Penavić J
    Acta Dermatovenerol Croat; 2021 Jul; 29(2):108-110. PubMed ID: 34477078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pilot study of fractional microneedling radiofrequency for hidradenitis suppurativa assessed by clinical response and histology.
    Yang JH; Cho SI; Kim DH; Yoon JY; Moon J; Kim JW; Choi S; Suh DH
    Clin Exp Dermatol; 2022 Feb; 47(2):335-342. PubMed ID: 34431555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update on Hormonal Therapy in Hidradenitis Suppurativa.
    Karagaiah P; Daveluy S; Ortega-Loayza A; Gulliver W; Szepietowski J; Grabbe S; Goldust M
    J Drugs Dermatol; 2023 Apr; 22(4):369-374. PubMed ID: 37026880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Topical and novel device-based therapies for mild hidradenitis suppurativa].
    Nikolakis G; von Stebut E
    Hautarzt; 2021 Aug; 72(8):676-685. PubMed ID: 34223936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Botulinum Toxin in Hidradenitis Suppurativa: A Systematic Review.
    Ravi M; Trinidad J
    J Drugs Dermatol; 2022 Apr; 21(4):408-412. PubMed ID: 35389587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Comparison of Alternative Medicine Users and Non-Users in Patients With Hidradenitis Suppurativa.
    Lane J; Emmerich V; Senthilnathan A; Kolli SS; Cardwell LA; Richardson IM; Feldman SR; Pichardo RO
    J Drugs Dermatol; 2021 Oct; 20(10):1072-1074. PubMed ID: 34636524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lasers and Intense Pulsed Light Hidradenitis Suppurativa.
    Saunte DM; Lapins J
    Dermatol Clin; 2016 Jan; 34(1):111-9. PubMed ID: 26617364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficacy and tolerability of tetracyclines and clindamycin plus rifampicin for the treatment of hidradenitis suppurativa: Results of a prospective European cohort study.
    van Straalen KR; Tzellos T; Guillem P; Benhadou F; Cuenca-Barrales C; Daxhelet M; Daoud M; Efthymiou O; Giamarellos-Bourboulis EJ; Jemec GBE; Katoulis AC; Koenig A; Lazaridou E; Marzano AV; Matusiak Ł; Molina-Leyva A; Moltrasio C; Pinter A; Potenza C; Romaní J; Saunte DM; Skroza N; Stergianou D; Szepietowski J; Trigoni A; Vilarrasa E; van der Zee HH
    J Am Acad Dermatol; 2021 Aug; 85(2):369-378. PubMed ID: 33484766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of 5-aminolevulinic acid photodynamic therapy in the treatment of hidradenitis suppurativa: a report of 5 cases.
    Andino Navarrete R; Hasson Nisis A; Parra Cares J
    Actas Dermosifiliogr; 2014; 105(6):614-7. PubMed ID: 24472519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apremilast for the Treatment of Mild-to-Moderate Hidradenitis Suppurativa in a Prospective, Open-Label, Phase 2 Study.
    Kerdel FR; Azevedo FA; Kerdel Don C; Don FA; Fabbrocini G; Kerdel FA
    J Drugs Dermatol; 2019 Feb; 18(2):170-176. PubMed ID: 30811140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Impact of LAight therapy on hidradenitis suppurativa care].
    Zimmer S; Basien K; von Stebut E
    Hautarzt; 2021 Jul; 72(7):586-594. PubMed ID: 34125251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.